Scientific Advisory Board

Iris Biotechnologies has established an outstanding scientific advisory board to provide guidance to management on the continuing development of its technology and product line.

Walter Hittelman, PhD., is Professor of Medicine and Chief of Cellular Oncology in the Department of Experimental Therapeutics at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Hittelman graduated from UC Berkeley with a PhD in biophysics, M.S. in nuclear engineering, and a B.S in mechanical engineering. He did his post doctorate training in cell biology at M. D. Anderson Cancer Center. Professor Hittelman serves on numerous national and international journal review committees including Cancer Research, Clinical Cancer Research, Science, Radiation Oncology, Biochemical Pharmacology, International Journal of Radiation Biology, Journal of Histochemistry and Cytochemistry, Cancer Chemotherapy and Pharmacology, American Journal of Pathology, Journal of the National Cancer Institute, Research, Mutation Research, Experimental Cell Research, Somatic Cell Genetics, Genetics and the New England Journal of Medicine. Professor Hittelman also serves on the NIH Center for Scientific Review and participates in Grant Review for the Dutch Cancer Society.

Wei Zhang, Ph.D., is Professor of Pathology and Director of the Cancer Genomics Core Laboratory at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Zhang has over 60 publications, has contributed various chapters to four books, and co-edited two books on genomics and bioinformatics. He has a PhD in molecular biology from the University of Texas Graduate School of Biomedical Sciences, and a BS in biochemistry from Beijing University, Beijing, China.

Wei-Dong Le, MD, Ph.D., is Professor of Neurology and Director of Parkinson’s Disease at Baylor College of Medicine in Houston, Texas. Dr. Le has received numerous honors and awards for his work on Parkinson’s and other diseases. He participates on national and international scientific review panels for various journals including the Journal of Life Science and the Journal of Analytical Biochemistry. He also participates on scientific panel reviews for the NIH SBIR/STTR research program. Dr. Le has over 40 publications, and has contributed various chapters to two books. He has an M.D. from Suzhou Medical College, China, and a Ph.D. in neurology from Shanghai 2nd Medical University, China. Dr. Le did his post-doctoral training in neurology at the Baylor College of Medicine.

Norman Tien, Ph.D., is Dean of the Case Western Reserve University School of Engineering in Cleveland, Ohio. Professor Tien is also Chairman of the Electrical Engineering and Computer Science Department, Nord Professor of Engineering and the Ohio Eminent Scholar in Condensed Matter Physics at Case. Dr. Tien was Co-Director of the MEMS Center at the University of California at Berkeley where he held joint faculty positions in the Electrical Engineering and Computer Science departments. Professor Tien’s research focuses on Microelectronics and Micro-Electro-Mechanical Systems (MEMS). He has more than forty publications, a dozen invited seminars, and ten conference and workshop presentations. Dr. Tien received his PhD in electrical and computer engineering from the University of California at San Diego, his MS in electrical engineering from the University of Illinois, Urbana- Champaign, and his BS in engineering physics from the University of California at Berkeley.

Charles Wiseman, MD, has more than 30 years of experience in the medical field as a practicing clinical oncologist, researcher, and professor. He is a Clinical Professor in the Division of Medical Oncology at the University of Southern California, School of Medicine and was the Director of the Immunotherapy Laboratory at the St. Vincent's Medical Center. Dr. Wiseman previously served as Chief of the Medical Breast Division Basic Research Program at the MD Anderson Cancer Center in Houston, Texas and also served as the Clinical Consultant for the Tunisian-American Breast Cancer Project, sponsored by the National Cancer Institute. He has contributed chapters in five books, has 30 journal articles and over 60 abstracts and presentations. Dr. Wiseman received board certifications from the American Board of Internal Medicine in 1972 and the American Board of Internal Medicine, Oncology, in 1977. He is a Fellow of the American College of Physicians and received both his BS and MD degrees from the University of California, Los Angeles.